McClung David 4/A
4/A · BioCardia, Inc. · Filed Apr 7, 2023
Insider Transaction Report
Form 4/AAmended
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
- Award
Common Stock
2022-05-12$1.32/sh−17,347$22,898→ 79,803 total
Footnotes (3)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person.
- [F2]The original Form 4 incorrectly reported that 20,632 shares had been withheld due to a clerical error. The corrected number is reported herein.
- [F3]The original Form 4 incorrectly reported that 76,518 shares were beneficially owned following the reported transaction. The corrected amount is reported herein.